{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:16:56Z","timestamp":1794475016822,"version":"4.9.1"},"reference-count":95,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:p>Sepsis and septic shock are major causes of morbidity, mortality, and health care costs for children worldwide, including &amp;gt;3 million deaths annually and, among survivors, risk for new or worsening functional impairments, including reduced quality of life, new respiratory, nutritional, or technological assistance, and recurrent severe infections. Advances in understanding sepsis pathophysiology highlight a need to update the definition and diagnostic criteria for pediatric sepsis and septic shock, whereas new data support an increasing role for automated screening algorithms and biomarker combinations to assist earlier recognition. Once sepsis or septic shock is suspected, attention to prompt initiation of broad-spectrum empiric antimicrobial therapy, fluid resuscitation, and vasoactive medications remain key components to initial management with several new and ongoing studies offering new insights into how to optimize this approach. Ultimately, a key goal is for screening to encompass as many children as possible at risk for sepsis and trigger early treatment without increasing unnecessary broad-spectrum antibiotics and preventable hospitalizations. Although the role for adjunctive treatment with corticosteroids and other metabolic therapies remains incompletely defined, ongoing studies will soon offer updated guidance for optimal use. Finally, we are increasingly moving toward an era in which precision therapeutics will bring novel strategies to improve outcomes, especially for the subset of children with sepsis-induced multiple organ dysfunction syndrome and sepsis subphenotypes for whom antibiotics, fluid, vasoactive medications, and supportive care remain insufficient.<\/jats:p>","DOI":"10.1542\/peds.2023-062967","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T03:13:26Z","timestamp":1702350806000},"source":"Crossref","is-referenced-by-count":80,"title":["Pediatric Sepsis Diagnosis, Management, and Sub-phenotypes"],"prefix":"10.1542","volume":"153","author":[{"given":"Scott L.","family":"Weiss","sequence":"first","affiliation":[{"name":"aDivision of Critical Care, Department of Pediatrics, Nemours Children\u2019s Health, Wilmington, Delaware"},{"name":"bDepartments of Pediatrics & Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"cDepartment of Anesthesiology and Critical Care, Children\u2019s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania"},{"name":"dPediatric Sepsis Program at the Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"10","key":"2024010102545879400_B1","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamapediatrics.2019.2570","article-title":"Cost of pediatric severe sepsis hospitalizations","volume":"173","author":"Carlton","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"4","key":"2024010102545879400_B2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamapediatrics.2018.4839","article-title":"Global case-fatality rates in pediatric severe sepsis and septic shock: a systematic review and meta-analysis","volume":"173","author":"Tan","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"10219","key":"2024010102545879400_B3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"2024010102545879400_B4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/CCM.0000000000005294","article-title":"Criteria for pediatric sepsis\u2013a systematic review and meta-analysis by the Pediatric Sepsis Definition Taskforce","volume":"50","author":"Menon","year":"2022","journal-title":"Crit Care Med"},{"issue":"1","key":"2024010102545879400_B5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13054-018-2052-7","article-title":"Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)","volume":"22","author":"Boeddha","year":"2018","journal-title":"Crit Care"},{"issue":"9","key":"2024010102545879400_B6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/PCC.0000000000001222","article-title":"The epidemiology of hospital death following pediatric severe sepsis: when, why, and how children with sepsis die","volume":"18","author":"Weiss","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2024010102545879400_B7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/PCC.0000000000002667","article-title":"Characteristics and timing of mortality in children dying with infections in North American PICUs","volume":"22","author":"Johnson","year":"2021","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"2024010102545879400_B8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00134-017-4701-8","article-title":"Prediction of pediatric sepsis mortality within 1 h of intensive care admission","volume":"43","author":"Schlapbach","year":"2017","journal-title":"Intensive Care Med"},{"issue":"5","key":"2024010102545879400_B9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000004272","article-title":"New medical device acquisition during pediatric severe sepsis hospitalizations","volume":"48","author":"Carlton","year":"2020","journal-title":"Crit Care Med"},{"issue":"9","key":"2024010102545879400_B10","doi-asserted-by":"crossref","first-page":"e2015214","DOI":"10.1001\/jamanetworkopen.2020.15214","article-title":"Comparison of outpatient health care use before and after pediatric severe sepsis","volume":"3","author":"Carlton","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2024010102545879400_B11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/CCM.0000000000003646","article-title":"Readmission diagnoses after pediatric severe sepsis hospitalization","volume":"47","author":"Carlton","year":"2019","journal-title":"Crit Care Med"},{"issue":"6","key":"2024010102545879400_B12","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1097\/PCC.0000000000002932","article-title":"Health resource use in survivors of pediatric septic shock in the United States","volume":"23","author":"Maddux","year":"2022","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2024010102545879400_B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CCM.0000000000004123","article-title":"Trajectory of mortality and health-related quality of life morbidity following community-acquired pediatric septic shock","volume":"48","author":"Zimmerman","year":"2020","journal-title":"Crit Care Med"},{"issue":"1","key":"2024010102545879400_B14","doi-asserted-by":"crossref","first-page":"e2022060819","DOI":"10.1542\/peds.2022-060819","article-title":"Frequency of and risk factors associated with hospital readmission after sepsis","volume":"152","author":"Dashefsky","year":"2023","journal-title":"Pediatrics"},{"key":"2024010102545879400_B15","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2024010102545879400_B16","doi-asserted-by":"crossref","first-page":"624279","DOI":"10.3389\/fimmu.2020.624279","article-title":"Immune deregulation in sepsis and septic shock: reversing immune paralysis by targeting PD-1\/PD-L1 pathway","volume":"11","author":"Nakamori","year":"2021","journal-title":"Front Immunol"},{"issue":"8","key":"2024010102545879400_B17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"2024010102545879400_B18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"issue":"8","key":"2024010102545879400_B19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PCC.0000000000001203","article-title":"Time for Sepsis-3 in children?","volume":"18","author":"Schlapbach","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2024010102545879400_B20","doi-asserted-by":"crossref","first-page":"e2021052565","DOI":"10.1542\/peds.2021-052565","article-title":"The current and future state of pediatric sepsis definitions: an international survey","volume":"149","author":"Morin","year":"2022","journal-title":"Pediatrics"},{"issue":"4","key":"2024010102545879400_B21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5847\/wjem.j.1920-8642.2022.060","article-title":"Comparing the precision of the pSOFA and SIRS scores in predicting sepsis-related deaths among hospitalized children: a multi-center retrospective cohort study","volume":"13","author":"Zhao","year":"2022","journal-title":"World J Emerg Med"},{"issue":"2","key":"2024010102545879400_B22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00134-017-5021-8","article-title":"Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit","volume":"44","author":"Schlapbach","year":"2018","journal-title":"Intensive Care Med"},{"issue":"7","key":"2024010102545879400_B23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamapediatrics.2022.1301","article-title":"Validation of the Pediatric Sequential Organ Failure Assessment Score and Evaluation of Third International Consensus Definitions for Sepsis and Septic Shock Definitions in the Pediatric Emergency Department","volume":"176","author":"Balamuth","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2024010102545879400_B24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1542\/peds.2021-052888B","article-title":"Pediatric Organ Dysfunction Information Update Mandate (PODIUM) contemporary organ dysfunction criteria: executive summary","volume":"149","author":"Bembea","year":"2022","journal-title":"Pediatrics"},{"issue":"8","key":"2024010102545879400_B25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/PCC.0000000000001182","article-title":"Can the pediatric logistic organ dysfunction-2 score on day 1 be used in clinical criteria for sepsis in children?","volume":"18","author":"Leclerc","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"2024010102545879400_B26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/CCM.0b013e31828a2bbd","article-title":"PELOD-2: an update of the PEdiatric logistic organ dysfunction score","volume":"41","author":"Leteurtre","year":"2013","journal-title":"Crit Care Med"},{"issue":"10","key":"2024010102545879400_B27","doi-asserted-by":"crossref","first-page":"e172352","DOI":"10.1001\/jamapediatrics.2017.2352","article-title":"Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the Sepsis-3 definitions in critically ill children","volume":"171","author":"Matics","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2024010102545879400_B28","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1542\/peds.2021-052888P","article-title":"Patterns of organ dysfunction in critically ill children based on PODIUM criteria","volume":"149","author":"Sanchez-Pinto","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"2024010102545879400_B29","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1542\/peds.2021-052888D","article-title":"Scoring systems for organ dysfunction and multiple organ dysfunction: the PODIUM Consensus Conference","volume":"149","author":"Schlapbach","year":"2022","journal-title":"Pediatrics"},{"issue":"6","key":"2024010102545879400_B30","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1097\/PCC.0000000000003263","article-title":"Operationalizing appropriate sepsis definitions in children worldwide: considerations for the pediatric sepsis definition taskforce","volume":"24","author":"Carrol","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"2024010102545879400_B31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","article-title":"Biomarkers of sepsis: time for a reappraisal","volume":"24","author":"Pierrakos","year":"2020","journal-title":"Crit Care"},{"issue":"3","key":"2024010102545879400_B32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamapediatrics.2016.3681","article-title":"Association between early lactate levels and 30-day mortality in clinically suspected sepsis in children","volume":"171","author":"Scott","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"2024010102545879400_B33","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1097\/PCC.0000000000002198","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"21","author":"Weiss","year":"2020","journal-title":"Pediatr Crit Care Med"},{"key":"2024010102545879400_B34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00134-019-05878-6","article-title":"Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children","volume":"46","author":"Weiss","year":"2020","journal-title":"Intensive Care Med"},{"issue":"7","key":"2024010102545879400_B35","doi-asserted-by":"crossref","first-page":"e01851-19","DOI":"10.1128\/JCM.01851-19","article-title":"Utility of procalcitonin as a biomarker for sepsis in children","volume":"58","author":"Downes","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2024010102545879400_B36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ajem.2021.09.081","article-title":"Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS","volume":"50","author":"Byler","year":"2021","journal-title":"Am J Emerg Med"},{"issue":"2","key":"2024010102545879400_B37","first-page":"327","article-title":"MicroRNAs as potential diagnostic new biomarkers in diagnosis of sepsis in pediatric patients","volume":"11","author":"Nour","year":"2022","journal-title":"Rep Biochem Mol Biol"},{"issue":"4","key":"2024010102545879400_B38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.201701-0066OC","article-title":"Improved risk stratification in pediatric septic shock using both protein and mRNA biomarkers. PERSEVERE-XP","volume":"196","author":"Wong","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2024010102545879400_B39","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1542\/peds.2021-052888O","article-title":"Endothelial dysfunction criteria in critically ill children: the PODIUM Consensus Conference","volume":"149","author":"Pierce","year":"2022","journal-title":"Pediatrics"},{"issue":"1","key":"2024010102545879400_B40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/08850666221109186","article-title":"Biomarkers of glycocalyx injury and endothelial activation are associated with clinical outcomes in patients with sepsis: a systematic review and meta-analysis","volume":"38","author":"Fern\u00e1ndez-Sarmiento","year":"2023","journal-title":"J Intensive Care Med"},{"issue":"9","key":"2024010102545879400_B41","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/nu15092100","article-title":"Citrulline, intestinal fatty acid-binding protein and the acute gastrointestinal injury score as predictors of gastrointestinal failure in patients with sepsis and septic shock","volume":"15","author":"Tyszko","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"2024010102545879400_B42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/CCM.0000000000004091","article-title":"Systemic endothelial activation is associated with early acute respiratory distress syndrome in children with extrapulmonary sepsis","volume":"48","author":"Whitney","year":"2020","journal-title":"Crit Care Med"},{"key":"2024010102545879400_B43","doi-asserted-by":"crossref","first-page":"564194","DOI":"10.3389\/fcimb.2020.564194","article-title":"Breath biopsy and discovery of exclusive volatile organic compounds for diagnosis of infectious diseases","volume":"10","author":"Beliz\u00e1rio","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"2024010102545879400_B44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.annemergmed.2017.03.019","article-title":"Improving recognition of pediatric severe sepsis in the emergency department: contributions of a vital sign-based electronic alert and bedside clinician identification","volume":"70","author":"Balamuth","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"12","key":"2024010102545879400_B45","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1097\/PCC.0000000000002101","article-title":"Performance of an automated screening algorithm for early detection of pediatric severe sepsis","volume":"20","author":"Eisenberg","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2024010102545879400_B46","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1055\/s-0038-1675211","article-title":"Automating a manual sepsis screening tool in a pediatric emergency department","volume":"9","author":"Lloyd","year":"2018","journal-title":"Appl Clin Inform"},{"issue":"2","key":"2024010102545879400_B47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41390-021-01708-y","article-title":"Pediatric sepsis screening in US hospitals","volume":"91","author":"Eisenberg","year":"2022","journal-title":"Pediatr Res"},{"issue":"3","key":"2024010102545879400_B48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00134-019-05872-y","article-title":"Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy","volume":"46","author":"Fleuren","year":"2020","journal-title":"Intensive Care Med"},{"issue":"10","key":"2024010102545879400_B49","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1097\/PCC.0000000000001666","article-title":"Applying artificial intelligence to identify physiomarkers predicting severe sepsis in the PICU","volume":"19","author":"Kamaleswaran","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"2024010102545879400_B50","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1542\/hpeds.2022-006592","article-title":"Characteristics and outcomes of sepsis presenting in inpatient pediatric settings","volume":"12","author":"Schafer","year":"2022","journal-title":"Hosp Pediatr"},{"issue":"10","key":"2024010102545879400_B51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201412-2323OC","article-title":"Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study","volume":"191","author":"Weiss","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2024010102545879400_B52","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1093\/cid\/ciac477","article-title":"Life-threatening complications of influenza vs coronavirus disease 2019 (COVID-19) in US children","volume":"76","author":"Halasa","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2024010102545879400_B53","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","article-title":"Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States","volume":"40","author":"Rice","year":"2012","journal-title":"Crit Care Med"},{"issue":"11","key":"2024010102545879400_B54","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/CCM.0000000000000509","article-title":"Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis","volume":"42","author":"Weiss","year":"2014","journal-title":"Crit Care Med"},{"issue":"6","key":"2024010102545879400_B55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PCC.0000000000001534","article-title":"Cardiac index changes with fluid bolus therapy in children with sepsis\u2013an observational study","volume":"19","author":"Long","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2024010102545879400_B56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamapediatrics.2017.4540","article-title":"Association between fluid balance and outcomes in critically ill children: a systematic review and meta-analysis","volume":"172","author":"Alobaidi","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2024010102545879400_B57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/OAEM.S368442","article-title":"Intravenous fluid bolus rates associated with outcomes in pediatric sepsis: a multi-center analysis","volume":"14","author":"Mullan","year":"2022","journal-title":"Open Access Emerg Med"},{"issue":"10","key":"2024010102545879400_B58","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1097\/PCC.0000000000001269","article-title":"Fluid bolus over 15-20 versus 5-10 minutes each in the first hour of resuscitation in children with septic shock: a randomized controlled trial","volume":"18","author":"Sankar","year":"2017","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2024010102545879400_B59","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1542\/peds.112.4.793","article-title":"Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome","volume":"112","author":"Han","year":"2003","journal-title":"Pediatrics"},{"issue":"9","key":"2024010102545879400_B60","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jama.1991.03470090076035","article-title":"Role of early fluid resuscitation in pediatric septic shock","volume":"266","author":"Carcillo","year":"1991","journal-title":"JAMA"},{"issue":"26","key":"2024010102545879400_B61","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa1101549","article-title":"Mortality after fluid bolus in African children with severe infection","volume":"364","author":"Maitland","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"2024010102545879400_B62","first-page":"e30029","article-title":"Fluid resuscitation and inotropic support in patients with septic shock treated in pediatric emergency department: an open-label trial","volume":"14","author":"Iramain","year":"2022","journal-title":"Cureus"},{"issue":"26","key":"2024010102545879400_B63","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"2024010102545879400_B64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"2024010102545879400_B65","article-title":"Performance of tools and measures to predict fluid responsiveness in pediatric shock and critical illness: a systematic review and meta-analysis","author":"Walker","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"2024010102545879400_B66","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/pan.14574","article-title":"Point-of-care ultrasonography to predict fluid responsiveness in children: a systematic review and meta-analysis","volume":"33","author":"Carioca","year":"2023","journal-title":"Paediatr Anaesth"},{"issue":"3","key":"2024010102545879400_B67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/PCC.0000000000003123","article-title":"Endothelial and glycocalyx biomarkers in children with sepsis after one bolus of unbalanced or balanced crystalloids","volume":"24","author":"Fern\u00e1ndez-Sarmiento","year":"2023","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"2024010102545879400_B68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jamapediatrics.2022.4912","article-title":"Effect of saline vs gluconate\/acetate-buffered solution vs lactate-buffered solution on serum chloride among children in the pediatric intensive care unit: the SPLYT-P randomized clinical trial","volume":"177","author":"Raman","year":"2023","journal-title":"JAMA Pediatr"},{"key":"2024010102545879400_B69","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005952","article-title":"Multiple electrolytes solution versus saline as bolus fluid for resuscitation in pediatric septic shock: a multicenter randomized clinical trial","author":"Sankar","year":"2023","journal-title":"Crit Care Med"},{"issue":"23","key":"2024010102545879400_B70","first-page":"2249","article-title":"Balanced electrolyte solution or saline in the critically ill","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"2024010102545879400_B71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s13063-021-05717-4","article-title":"PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial","volume":"22","author":"Weiss","year":"2021","journal-title":"Trials"},{"issue":"11","key":"2024010102545879400_B72","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1097\/PCC.0000000000000954","article-title":"Double-blind randomized clinical trial comparing dopamine and epinephrine in pediatric fluid-refractory hypotensive septic shock","volume":"17","author":"Ramaswamy","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"11","key":"2024010102545879400_B73","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1097\/CCM.0000000000001260","article-title":"Double-blind prospective randomized controlled trial of dopamine versus epinephrine as first-line vasoactive drugs in pediatric septic shock","volume":"43","author":"Ventura","year":"2015","journal-title":"Crit Care Med"},{"issue":"4","key":"2024010102545879400_B74","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1542\/peds.2007-1979","article-title":"Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care","volume":"122","author":"Brierley","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"2024010102545879400_B75","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"2024010102545879400_B76","doi-asserted-by":"crossref","first-page":"e0036","DOI":"10.1097\/CCE.0000000000000036","article-title":"Synthetic human angiotensin II in pediatric patients with vasodilatory shock: a report on two patients","volume":"1","author":"Bailey","year":"2019","journal-title":"Crit Care Explor"},{"issue":"2","key":"2024010102545879400_B77","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0000000000001380","article-title":"Evaluation of early corticosteroid therapy in management of pediatric septic shock in pediatric intensive care patients: a randomized clinical study","volume":"36","author":"El-Nawawy","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"2024010102545879400_B78","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"2024010102545879400_B79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"2024010102545879400_B80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"2024010102545879400_B81","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in sepsis: an updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Crit Care Med"},{"issue":"5","key":"2024010102545879400_B82","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.chest.2017.07.014","article-title":"Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction","volume":"152","author":"Barabutis","year":"2017","journal-title":"Chest"},{"issue":"7","key":"2024010102545879400_B83","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1164\/rccm.201908-1543LE","article-title":"Hydrocortisone-ascorbic acid-thiamine use associated with lower mortality in pediatric septic shock","volume":"201","author":"Wald","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"25","key":"2024010102545879400_B84","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","article-title":"Intravenous vitamin C in adults with sepsis in the intensive care Unit","volume":"386","author":"Lamontagne","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"2024010102545879400_B85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2019.22176","article-title":"Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial","volume":"323","author":"Fujii","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"2024010102545879400_B86","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2020.11946","article-title":"Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial","volume":"324","author":"Moskowitz","year":"2020","journal-title":"JAMA"},{"issue":"20","key":"2024010102545879400_B87","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"2024010102545879400_B88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/SHK.0000000000001906","article-title":"Temperature trajectory sub-phenotypes and the immuno-inflammatory response in pediatric sepsis","volume":"57","author":"Yehya","year":"2022","journal-title":"Shock"},{"issue":"12","key":"2024010102545879400_B89","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2024010102545879400_B90","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med"},{"issue":"3","key":"2024010102545879400_B91","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1097\/CCM.0000000000003559","article-title":"Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the Thrombocytopenia-Associated Multiple Organ Failure Network Prospective Experience","volume":"47","author":"Fortenberry","year":"2019","journal-title":"Crit Care Med"},{"issue":"2","key":"2024010102545879400_B92","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"2024010102545879400_B93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"2024010102545879400_B94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"issue":"1","key":"2024010102545879400_B95","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/CCM.0000000000004709","article-title":"External corroboration that corticosteroids may be harmful to septic shock endotype A patients","volume":"49","author":"Wong","year":"2021","journal-title":"Crit Care Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062967\/1584836\/peds.2023-062967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-062967\/1584836\/peds.2023-062967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,31]],"date-time":"2023-12-31T21:55:53Z","timestamp":1704059753000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/153\/1\/e2023062967\/196195\/Pediatric-Sepsis-Diagnosis-Management-and-Sub"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-062967","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"article-number":"e2023062967"}}